Form 8-K - Current report:
SEC Accession No. 0001193125-20-298237
Filing Date
2020-11-19
Accepted
2020-11-19 17:06:55
Documents
21
Period of Report
2020-11-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d76696d8k.htm   iXBRL 8-K 34579
2 EX-1.1 d76696dex11.htm EX-1.1 157896
3 EX-4.1 d76696dex41.htm EX-4.1 100801
4 EX-5.1 d76696dex51.htm EX-5.1 12489
5 EX-99.1 d76696dex991.htm EX-99.1 10428
6 EX-99.2 d76696dex992.htm EX-99.2 10610
10 GRAPHIC g76696dsp36.jpg GRAPHIC 3350
11 GRAPHIC g76696dsp37.jpg GRAPHIC 2619
12 GRAPHIC g76696dsp38_40.jpg GRAPHIC 6702
13 GRAPHIC g76696dsp39_41.jpg GRAPHIC 4621
  Complete submission text file 0001193125-20-298237.txt   561477

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA onct-20201117.xsd EX-101.SCH 3074
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20201117_lab.xml EX-101.LAB 18140
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20201117_pre.xml EX-101.PRE 11411
14 EXTRACTED XBRL INSTANCE DOCUMENT d76696d8k_htm.xml XML 3417
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 201329516
SIC: 2834 Pharmaceutical Preparations